Armin Spura, Ph.D.
CEO, Crown Bioscience
Dr. Armin Spura joined Crown Bioscience from CareDx, a leader in transplant diagnostics, where he led the Asia Pacific and Greater China expansion strategy. Before CareDx, he ran the global product commercialization efforts for Wuxi NextCODE's data analysis and AI solutions.
Prior to Wuxi NextCODE Dr. Spura held multiple leadership positions at Life Technologies and Thermo Fisher Scientific, where he was General Manager for a China-based joint venture with Da'An Diagnostics, as well as GM for Professional Services for the Genomics Business. Earlier in his career, Dr. Spura helped to grow two start-up companies: Ingenuity Systems (acquired by Qiagen) and ForteBio (now part of Danaher).
Dr. Spura studied Biochemistry in Germany and received his Ph.D. in Molecular Biology from Brown University.
